These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 200089)

  • 21. The effect of cholestyramine on the elimination of cholesterol as bile acids in patients with hyperlipoproteinaemia type II and IV.
    Einarsson K; Hellström K; Kallner M
    Eur J Clin Invest; 1974 Dec; 4(6):405-10. PubMed ID: 4442440
    [No Abstract]   [Full Text] [Related]  

  • 22. Hypertriglyceridemia: a relative contraindication to the use of bile acid-binding resins?
    Denke MA; Grundy SM
    Hepatology; 1988; 8(4):974-5. PubMed ID: 3391527
    [No Abstract]   [Full Text] [Related]  

  • 23. [Anion exchange resin].
    Nakaya N
    Nihon Rinsho; 2001 Mar; 59 Suppl 3():642-9. PubMed ID: 11347147
    [No Abstract]   [Full Text] [Related]  

  • 24. Clinical inquiry. Postcholecystectomy diarrhea: what relieves it?
    Danley T; St Anna L
    J Fam Pract; 2011 Oct; 60(10):632c-d. PubMed ID: 21977493
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Treatment of hypercholesterolemia and hypertriglyceridemia by anion exchange resin.
    Bressler R; Nowlin J; Bogdonoff MD
    South Med J; 1966 Sep; 59(9):1097-103. PubMed ID: 5919781
    [No Abstract]   [Full Text] [Related]  

  • 26. Interruption of the enterohepatic circulation of bile acids in man: comparative effects of cholestyramine and ileal exclusion on cholesterol metabolism.
    Grundy SM; Ahrens EH; Salen G
    J Lab Clin Med; 1971 Jul; 78(1):94-121. PubMed ID: 5569253
    [No Abstract]   [Full Text] [Related]  

  • 27. Bile acid kinetics and steroid balance during nicotinic acid therapy in patients with hyperlipoproteinemia types II and IV.
    Einarsson K; Hellström K; Leijd B
    J Lab Clin Med; 1977 Oct; 90(4):613-22. PubMed ID: 198500
    [No Abstract]   [Full Text] [Related]  

  • 28. [Hypolipidemic effect of cholestyramine in patients affected by type II hyperlipoproteinemia].
    Sauvanet JP; Drouin P; Mejean L; Lambert D; Debry G
    Therapie; 1978; 33(5):615-22. PubMed ID: 217121
    [No Abstract]   [Full Text] [Related]  

  • 29. The fate of the orally administered bile acid sequestrant, polidexide, in humans.
    Simons LA
    Clin Exp Pharmacol Physiol; 1976; 3(1):99-101. PubMed ID: 971556
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinical pharmacology of DEAE-dextran for long-term administration (one year).
    Pupita F; Barone A
    Int J Clin Pharmacol Res; 1983; 3(4):287-93. PubMed ID: 6206004
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The effects of cholestyramine, colestipol, and ADR-132 on the rat prostate and dunning R-3327 adenocarcinoma.
    Brown WJ; Karr JP; McGarry M; Williams PD; Hagerman LM; Murphy GP
    J Surg Oncol; 1983 Apr; 22(4):273-7. PubMed ID: 6834849
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of hypolipidemic drugs on bile acid metabolism in man.
    Miettinen TA
    Adv Lipid Res; 1981; 18():65-97. PubMed ID: 6275661
    [No Abstract]   [Full Text] [Related]  

  • 33. Hypolipidemic effects of orally administered dextran and cellulose anion exchangers in cockerels and dogs.
    Parkinson TM
    J Lipid Res; 1967 Jan; 8(1):24-9. PubMed ID: 14564701
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mechanisms of action of cholestyramine in the treatment of hypercholesterolemia.
    Nazir DJ; Horlick L; Kudchodkar BJ; Sodhi HS
    Circulation; 1972 Jul; 46(1):95-102. PubMed ID: 5039828
    [No Abstract]   [Full Text] [Related]  

  • 35. [Preliminary results of an open study on the effects of DEAE-dextran on various lipid metabolism parameters in dyslipidemic subjects].
    Graziani P; Leproux GB; Gavelli MS; Vitaliano E; Serra T; Santini G
    Clin Ter; 1989 Nov; 131(3):183-7. PubMed ID: 2482151
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Colestimide: the efficacy of a novel anion-exchange resin in cholestatic disorders.
    Matsuzaki Y
    J Gastroenterol Hepatol; 2002 Nov; 17(11):1133-5. PubMed ID: 12453270
    [No Abstract]   [Full Text] [Related]  

  • 37. Treatment of pruritus in cholestasis of pregnancy with a new anion exchange resin (Secholex).
    Samsioe G; Johnson P; Gustafson A
    Acta Obstet Gynecol Scand; 1975; 54(4):333-40. PubMed ID: 1199702
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Cardiovascular system drugs. 9/12. Antilipemics--II. Fibrates and colestyramine].
    Nerich V; Limat S
    Soins; 2005; (692):57-8. PubMed ID: 15787412
    [No Abstract]   [Full Text] [Related]  

  • 39. A comparison of cholestyramine and nicotinic acid in the treatment of familial type II hyperlipoproteinaemia.
    Mann JI; Harding PA; Turner RC; Wilkinson RH
    Br J Clin Pharmacol; 1977 Jun; 4(3):305-8. PubMed ID: 197982
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cholestyramine for elevated serum cholesterol.
    Med Lett Drugs Ther; 1974 Apr; 16(8):33-4. PubMed ID: 4362570
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.